Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4784335 | 5888833 | I | 4784335-9 | 20050910 | 20050922 | 20050930 | EXP | PHBS2005JP14133 | NOVARTIS PHARMACEUTICALS CORP. | 56 | YR | M | Y | 20050929 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4784335 | 1006470461 | PS | ZADITEN | 1 | ORAL | 2 MG/DAY | 021066 | ||||
| 4784335 | 1006470462 | C | OXAROL | 2 | TOPICAL |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4784335 | 1006470461 | URTICARIA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4784335 | HO |
| 4784335 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 4784335 | ALANINE AMINOTRANSFERASE INCREASED |
| 4784335 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 4784335 | BLOOD ALKALINE PHOSPHATASE INCREASED |
| 4784335 | BLOOD BILIRUBIN INCREASED |
| 4784335 | BLOOD LACTATE DEHYDROGENASE INCREASED |
| 4784335 | GAMMA-GLUTAMYLTRANSFERASE INCREASED |
| 4784335 | LIVER DISORDER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4784335 | 1006470461 | 20050907 | 20050921 | 21600 | MIN |
| 4784335 | 1006470462 | 20050907 | 20050921 | 21600 | MIN |